Financial Impact of Cancer Treatment on Privately Insured Individuals in Lebanon

Overview

This study provides a comprehensive analysis of the financial burden of cancer treatment on privately insured individuals in Lebanon from 2018 to 2024. It highlights significant increases in annual spending and identifies a small high-cost subgroup that contributes disproportionately to total expenditures.

Background

Cancer poses a substantial financial challenge globally, particularly in low- and middle-income countries where resources for cancer care are limited. In Lebanon, private insurance plays a crucial role in financing cancer treatment, yet there has been a lack of detailed research on the economic implications for this population. Understanding these financial dynamics is essential for developing sustainable healthcare policies.

Data Highlights

Key Findings

• Total expenditure on cancer treatment reached USD 239.9 million over seven years.
• Breast cancer was the most common diagnosis, accounting for 19.7% of cases.
• Annual spending increased from USD 35.7 million in 2018 to USD 48.9 million in 2024.
• Cancer medicines represented the largest expenditure category at 37.8% of total spend.
• The high-cost cohort (1.7% of patients) generated USD 55.1 million, primarily driven by lung cancer.
• Per-member-per-year costs rose significantly with age, reaching USD 606 for patients aged 65 and older.

Clinical Implications

The findings indicate a growing financial burden associated with cancer treatment in Lebanon's privately insured population. This data can inform healthcare policymakers and insurers.

Conclusion

This study represents the first longitudinal analysis of cancer-related expenditures in Lebanon's private insurance sector, revealing critical insights into the economic burden of cancer care. The concentration of costs within a small high-cost subgroup highlights the need for tailored financial management strategies.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Financial Impact of Cancer Treatment on Privately Insured Individuals in Lebanon
2. the asco post — Study Finds the Financial Hardship Caused by Cancer Is Long-Lasting for Many Working-Age Adults
3. DIGITAL HEALTH — Feasibility and acceptability of FinCare: A personalized online tool for estimating out-of-pocket costs for cancer treatment
4. the asco post — Financial Hardships Caused by Cancer Are Long-Lasting for Many Working-Age Adults
5. The ASCO Post — Financial Hardships Caused by Cancer Are Long-Lasting for Many Working-Age Adults
6. Study Finds the Financial Hardship Caused by Cancer Is Long-Lasting for Many Working-Age Adults
7. Feasibility and acceptability of FinCare: A personalized online tool for estimating out-of-pocket costs for cancer treatment
8. ESMO expert consensus statements on the screening and
9. Financial Navigation for People Newly Diagnosed With Cancer: Primary Outcomes From the Cancer Financial Experience Randomized Trial | JCO Oncology Practice
10. The health system in Lebanon is characterized by a dominant private sector, a very active NGO sector, and a public sector that has been trying to progressively regain its leadership and regulatory role over the past two decades. The current complex crises have heavily impacted the health system, decreasing availability, affordability and accessibility, jeopardizing the quality of health care in general, and threatening the health system’s sustainability and resilience.